Zinzino group revenue increased with a total of 60 % in Q1 compared with the previous year.
The revenue in March for Zinzino's sales markets increased by 79% and amounted to SEK 268.0 (149.7) million. Faun Pharma's external sales decreased and amounted to SEK 7.1 (9.8) million. Overall, the Group increased revenues by 72% to SEK 275.1 (159.5) million compared with the previous year.
The group revenue increased with 60 % for Q1 2025 compared with the first quarter last year and amounted to SEK 725.9 (454.5) million.
Revenues were distributed as follows:
Countries in regions: -The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden -Central Europe: Austria, Germany, Switzerland -East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania -South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Island. -The Baltics: Estonia, Latvia, Lithuania -North America: Canada, USA, Mexico -Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand -Africa: South Africa
For more information: Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, www.zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: Carnegie Investment Bank AB (publ.)
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/zinzino/r/zinzino-ab–publ–preliminary-sales-report-q1-2025,c4130427
The following files are available for download:
https://c212.net/c/img/favicon.png?sn=IO56970&sd=2025-04-03
View original content:https://www.prnewswire.com/news-releases/zinzino-ab-publ-preliminary-sales-report-q1-2025-302419629.html
SOURCE Zinzino
https://rt.newswire.ca/rt.gif?NewsItemId=IO56970&Transmission_Id=202504030411PR_NEWS_USPR_____IO56970&DateId=20250403